HM Payson & Co. Has $162,000 Position in Revvity, Inc. (NYSE:RVTY)

HM Payson & Co. cut its stake in shares of Revvity, Inc. (NYSE:RVTY) by 8.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,271 shares of the company’s stock after selling 123 shares during the quarter. HM Payson & Co.’s holdings in Revvity were worth $162,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in RVTY. Rothschild Investment LLC bought a new position in Revvity in the second quarter valued at about $25,000. EverSource Wealth Advisors LLC raised its holdings in Revvity by 74.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock valued at $41,000 after buying an additional 167 shares during the last quarter. Family Firm Inc. acquired a new stake in Revvity during the 2nd quarter worth approximately $43,000. Fairfield Financial Advisors LTD bought a new stake in Revvity during the 2nd quarter worth approximately $43,000. Finally, EntryPoint Capital LLC acquired a new position in Revvity in the 1st quarter valued at approximately $48,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently weighed in on RVTY shares. Barclays raised shares of Revvity from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $125.00 to $140.00 in a research note on Tuesday, October 15th. Jefferies Financial Group raised their price objective on Revvity from $115.00 to $125.00 and gave the stock a “hold” rating in a research report on Monday, July 29th. Leerink Partnrs upgraded shares of Revvity to a “strong-buy” rating in a report on Monday, July 8th. TD Cowen upped their price objective on shares of Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Finally, Bank of America lifted their target price on shares of Revvity from $118.00 to $127.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 30th. Seven analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $128.79.

Revvity Stock Up 2.1 %

RVTY stock opened at $121.04 on Friday. The stock’s 50 day simple moving average is $121.39 and its 200 day simple moving average is $113.92. The company has a market cap of $14.93 billion, a P/E ratio of 87.71, a price-to-earnings-growth ratio of 3.31 and a beta of 1.05. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. Revvity, Inc. has a fifty-two week low of $82.17 and a fifty-two week high of $128.15.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 7th. Investors of record on Friday, January 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date of this dividend is Friday, January 17th. Revvity’s dividend payout ratio is currently 20.29%.

Insider Activity at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 2,153 shares of the company’s stock in a transaction on Monday, October 7th. The shares were sold at an average price of $122.09, for a total transaction of $262,859.77. Following the transaction, the insider now owns 23,960 shares in the company, valued at approximately $2,925,276.40. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Revvity news, insider Joel S. Goldberg sold 3,500 shares of Revvity stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the transaction, the insider now owns 33,400 shares in the company, valued at approximately $3,936,524. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tajinder S. Vohra sold 2,153 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the sale, the insider now directly owns 23,960 shares of the company’s stock, valued at $2,925,276.40. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,807 shares of company stock valued at $937,576. 0.60% of the stock is owned by company insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.